BeyondSpring BYSI
NASDAQ BYSI
$0.75 +0.03 (+3.47%)
As of: Aug 21, 2026 · 2:03 PM EDT

BeyondSpring (BYSI) EBITDA Margin Growth (3y) (2024)

BeyondSpring (BYSI) EBITDA Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.81 Bn 130.96 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.07 Bn 78.08 Bn 3.93 Bn -204.00
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn -537.00
4 Moderna 55.64 Bn 50.50 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.99 Bn 36.89 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn 9,003.00
7 BioNTech SE 27.69 Bn 9.29 Bn 668.28 Mn -11,254.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.36 Bn 26.52 Bn - -2,649.00
10 BeyondSpring 30.64 Mn 30.64 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 532,697.00